Cargando…
Preferences and acceptability for long‐acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya
INTRODUCTION: Long‐acting pre‐exposure prophylaxis (PrEP) options could overcome barriers to oral PrEP persistence during pregnancy and postpartum. We evaluated long‐acting PrEP preferences among oral PrEP‐experienced pregnant and postpartum women in South Africa and Kenya, countries with high PrEP...
Autores principales: | Wara, Nafisa J., Mvududu, Rufaro, Marwa, Mary M., Gómez, Laurén, Mashele, Nyiko, Orrell, Catherine, Moucheraud, Corrina, Kinuthia, John, John‐Stewart, Grace, Myer, Landon, Hoffman, Risa, Pintye, Jillian, Davey, Dvora L. Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206415/ https://www.ncbi.nlm.nih.gov/pubmed/37221983 http://dx.doi.org/10.1002/jia2.26088 |
Ejemplares similares
-
Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence
por: Moran, Alexander, et al.
Publicado: (2021) -
Early pre‐exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa
por: Joseph Davey, Dvora Leah, et al.
Publicado: (2022) -
PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa
por: Davey, Dvora L Joseph, et al.
Publicado: (2020) -
Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial
por: Joseph Davey, Dvora Leah, et al.
Publicado: (2022) -
Response to “Being prepared to evaluate pregnancy PrEP”
por: Dettinger, Julia C, et al.
Publicado: (2019)